Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.
You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.
Other companies in Monopar Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX) and Connect Biopharma Hldgs (NASDAQ:CNTB).
Monopar Therapeutics has a consensus price target of $18.60.
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $16.16 last updated November 8, 2024 at 7:47 PM EST.
There are no upcoming dividends for Monopar Therapeutics.
Monopar Therapeutics’s Q3 earnings are confirmed for Friday, November 8, 2024.
There is no upcoming split for Monopar Therapeutics.
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.